Validation of the mantle cell lymphoma i
โ
Stephen D. Smith; Eric Hsi; Brian Bolwell; Brad Pohlman; Robert Dean; Meagan Eff
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 317 KB
๐ 1 views
Mantle cell lymphoma (MCL) is a unique, recently recognized entity with a variable clinical course [1]. Its historical grouping as an indolent lymphoma belies its common behavior, which is generally aggressive and incurable, with a median survival of about 5 years with modern therapy [2]. In an effo